Abstract |
The main indication for the application of Disalunil in the convalescent care of recidive calcium- lithiasis patients is renal hypercalciuria. Treatment with 50 mg Disalunil/d reduced the rate of recidivation by two thirds. Even during long-term application of this therapy over 3-7 years, side effects were slight and did not require any cessation of therapy.
|
Authors | C Bick, G Brien, D Fahlenkamp, R Koch |
Journal | Zeitschrift fur Urologie und Nephrologie
(Z Urol Nephrol)
Vol. 75
Issue 11
Pg. 753-8
(Nov 1982)
ISSN: 0044-3611 [Print] Germany |
Vernacular Title | Hydrochlorothiazide in der Metaphylaxe der rezidivierenden Kalzium-oxalatlithiasis. |
PMID | 7164602
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Hydrochlorothiazide
- Calcium Oxalate
- Potassium
|
Topics |
- Adult
- Calcium Oxalate
(urine)
- Female
- Humans
- Hydrochlorothiazide
(therapeutic use)
- Male
- Middle Aged
- Potassium
(blood)
- Recurrence
- Urinary Calculi
(prevention & control, urine)
|